S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
LON:ZTF

Zotefoams (ZTF) Share Price, News & Analysis

GBX 383
+13.00 (+3.51%)
(As of 04:35 PM ET)
Today's Range
371
389
50-Day Range
320
407
52-Week Range
258.55
415
Volume
70,494 shs
Average Volume
115,322 shs
Market Capitalization
£187.10 million
P/E Ratio
2,015.79
Dividend Yield
1.83%
Price Target
N/A
ZTF stock logo

About Zotefoams Stock (LON:ZTF)

Zotefoams plc, together with its subsidiaries, manufactures, distributes, and sells polyolefin block foams in the United Kingdom, Europe, North America, and internationally. It offers AZOTE, a polyolefin foam under the Plastazote, Evazote, and Supazote, AZOTE Adapt brands; and various high-performance foams manufactured from fluoropolymers, engineering polymers, and specialty elastomers under the ZOTEK brand; Ecozote foam that offers circularity and reduce reliance on fossil fuel-derived raw materials. The company also provides T-FIT, a clean insulation system that is used in the pharmaceutical, biotech, and semiconductor cleanroom industries; and ReZorce circular packaging, a range of mono-material barrier packaging. In addition, it owns, and licenses patented MuCell microcellular foam technology, as well as sells related machinery. The company primarily serves the automotive, aerospace, product protection, industrial parts, marine, building and construction, military, and sports and leisure industries. Zotefoams plc was founded in 1921 and is headquartered in Croydon, the United Kingdom.

ZTF Stock Price History

ZTF Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
What Does Zotefoams plc's (LON:ZTF) Share Price Indicate?
Zotefoams plc (ZTF.L)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
A Look At The Fair Value Of Zotefoams plc (LON:ZTF)
Zotefoams' (LON:ZTF) Returns On Capital Are Heading Higher
Zotefoams PLC ZTF
Is It Time To Consider Buying Zotefoams plc (LON:ZTF)?
See More Headlines
Receive ZTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zotefoams and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/11/2020
Today
4/19/2024
Ex-Dividend for 6/3 Dividend
5/02/2024
Dividend Payable
6/03/2024

Industry, Sector and Symbol

Industry
Specialty Chemicals
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
580
Year Founded
N/A

Profitability

Net Income
£9.24 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£126.97 million
Cash Flow
GBX 20.30 per share
Book Value
GBX 238 per share

Miscellaneous

Free Float
N/A
Market Cap
£187.10 million
Optionable
Not Optionable
Beta
1.26
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

ZTF Stock Analysis - Frequently Asked Questions

How have ZTF shares performed in 2024?

Zotefoams' stock was trading at GBX 335 at the beginning of the year. Since then, ZTF shares have increased by 14.3% and is now trading at GBX 383.
View the best growth stocks for 2024 here
.

How were Zotefoams' earnings last quarter?

Zotefoams plc (LON:ZTF) released its quarterly earnings data on Tuesday, August, 11th. The company reported $4.48 EPS for the quarter. Zotefoams had a trailing twelve-month return on equity of 8.20% and a net margin of 7.28%.

How often does Zotefoams pay dividends? What is the dividend yield for Zotefoams?

Zotefoams announced a dividend on Tuesday, March 19th. Stockholders of record on Thursday, May 2nd will be paid a dividend of GBX 4.90 per share on Monday, June 3rd. This represents a yield of 1.46%. The ex-dividend date is Thursday, May 2nd. This is a positive change from the stock's previous dividend of GBX 2.28. The official announcement can be viewed at this link.
Read our dividend analysis for ZTF
.

Is Zotefoams a good dividend stock?

Zotefoams (LON:ZTF) pays an annual dividend of GBX 7 per share and currently has a dividend yield of 1.91%. The dividend payout ratio is 3,684.21%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for ZTF.

What other stocks do shareholders of Zotefoams own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Zotefoams investors own include Applied Graphene Materials (AGM), NetApp (NTAP), Twitter (TWTR), FD Technologies (FDP), TiVo (TIVO), Vodafone Group Public (VOD), EMC (EMC), Eros STX Global (EROS), Frontier Developments (FDEV) and FDM Group (FDM).

How do I buy shares of Zotefoams?

Shares of ZTF stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:ZTF) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners